Related Experiment Video
Updated: Mar 26, 2026
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
Published on: January 27, 2022
Concise Review: Cell Therapies for Stroke and Traumatic Brain Injury: Targeting Microglia
Sean I Savitz1, Charles S Cox2
1Department of Neurology, UT-Health, Houston, Texas, USA.
Abstract:
We present a model hypothesis of how several types of cell therapies may target microglia as one of the principal cell types contributing to the inflammatory response after brain injury and discuss how imaging of brain inflammation could potentially be applied to develop biomarkers in patients with stroke and TBI enrolled into stem cell clinical trials.
Insights
Cell therapies may target microglia, key players in brain inflammation after injury. Imaging brain inflammation could help develop biomarkers for patients in stem cell trials for stroke and traumatic brain injury (TBI).
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Microglia are central to the inflammatory response following central nervous system (CNS) injury, including stroke and traumatic brain injury (TBI).
- Cell therapies are being investigated for neuroprotective and regenerative effects after brain injury.
- Understanding the precise mechanisms of cell therapy action, particularly their interaction with the neuroinflammatory environment, is crucial.
Purpose of the Study:
- To propose a model hypothesis on how cell therapies can target microglia in the context of brain injury.
- To explore the potential of advanced imaging techniques for assessing brain inflammation in patients undergoing cell therapy.
- To discuss the development of imaging-based biomarkers for clinical trials involving stem cell therapies for neurological conditions.
Main Methods:
- Review and synthesis of existing literature on microglia function, neuroinflammation, and cell therapy mechanisms.
- Conceptual modeling of cell therapy-microglia interactions.
- Discussion of current and emerging neuroimaging modalities applicable to brain inflammation.
Main Results:
- A hypothesis is presented suggesting that cell therapies can modulate microglial activity, thereby influencing the inflammatory cascade post-brain injury.
- The potential utility of in vivo imaging techniques (e.g., PET, MRI) for visualizing and quantifying neuroinflammation is highlighted.
- The feasibility of developing imaging biomarkers to track therapeutic response and disease progression in clinical trials is discussed.
Conclusions:
- Cell therapies hold promise for targeting microglia-mediated inflammation after brain injury.
- Neuroimaging offers a powerful, non-invasive approach to develop biomarkers for patient stratification and treatment monitoring in cell therapy trials.
- This framework could accelerate the clinical translation of cell-based interventions for stroke and TBI by providing objective measures of therapeutic efficacy.
